14th Annual RNA Therapeutics Conference Copthorne Tara Hotel London Kensington, London

RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. This is reflected with the value of the global antisense and RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%. With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.

Benefits of attending:
– Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities
– Investigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics